Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Liabilities (2020 - 2021)

Protagonist Therapeutics (PTGX) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $121000.0 as the latest value for Q3 2021.

  • Quarterly Other Non-Current Liabilities fell 28.82% to $121000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $121000.0 through Sep 2021, down 28.82% year-over-year, with the annual reading at $121000.0 for FY2020, N/A changed from the prior year.
  • Other Non-Current Liabilities hit $121000.0 in Q3 2021 for Protagonist Therapeutics, roughly flat from $121000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $170000.0 in Q3 2020 to a low of $92000.0 in Q2 2020.